Remission-driven discontinuation shapes the observed duration of emicizumab in acquired hemophilia A. Comment on: “Short-term emicizumab in patients with acquired hemophilia A”
Open access0 citations
Abstract
Not available.
// Source
Authors: Manuel Rodriguez Lopez, Michael Calviño Suarez
Institutions: Complexo Hospitalario Universitario A Coruña, University Hospital Complex Of Vigo